Stem Cell Panel Approves Of Collection Program

Hirsh, Lou
March 2011
San Diego Business Journal;3/28/2011, Vol. 32 Issue 13, p42
The article reports on the decision of Stem Research Oversight Committee to approve the next phase of a stem cell collection program of International Stem Cell Corp.


Related Articles

  • Stem-cell lines set for German research.  // Medical Device Daily;3/4/2008, Vol. 12 Issue 43, p8 

    The article reports on the use of International Stem Cell's (ISCO) human parthenogenetic stem cell lines in Germany in studies aimed at creating cell types to treat neural diseases. The study will be headed by Albrecht Mueller of the University of Wuerzburg. ISCO chief executive Kenneth Aldrich...

  • International Stem Cell Corp Receives Important Approvals Towards Creating New Parthenogenetic Stem Cell Lines in the US.  // Biomedical Market Newsletter;3/31/2011, p104 

    The article reports on the approval given to International Stem Cell Corp. in order to move forward to the next phase of its stem cell banking program. The approval has come from Stem Cell Research Oversight (SCRO) committee in which they are the responsible for reviewing the ethics and...

  • Four firms in plan to develop embryonic stem cell technology.  // Medical Device Daily;4/4/2008, Vol. 12 Issue 66, p6 

    The article reports on a letter of intent signed by BioTime and its Embryome Sciences subsidiary with International Stem Cell Corp. and its subsidiary Lifeline Cell Technology to jointly produce and distribute a variety of research products from human embryonic stem cell technology. According to...

  • Agreements/contracts.  // Medical Device Daily;3/13/2009, Vol. 13 Issue 48, p10 

    The article reports on a collaboration between International Stem Cell and tissue engineers at Cytograft Tissue Engineering to design a custom cell culture medium to cultivate living human vascular grafts. It is noted that the grafts will be used in future human clinical trials. Scientists at...

  • ISCO Scientists to Present Results of Recent Stem Cell Research on Central Nervous System and Liver Diseases at Annual Meeting of American Society of Gene and Cell Therapy.  // Biomedical Market Newsletter;5/17/2011, p565 

    The article focuses on the announcement of International Stem Cell Corp. (ISCO) that doctors Ruslan Semechkin and Nikolay Turovets will present the human parthenogenetic stem cells (HPSC) research at the 14th Annual Meeting of the American Society of Gene and Cell Therapy in Seattle, Washington....

  • The Court of Justice of the European Union Clarifies when Human Embryonic Stem Cells Can Be Patented. Bonadio, Enrico; Rovati, Angelo Maria // European Journal of Risk Regulation;2015, Vol. 6 Issue 2, p293 

    The article discusses the European court case International Stem Cell Corporation v. Comptroller General of Patents, Designs and Trade Marks regarding the embryonic stem cell technologies. The Court of Justice of the European Union (CJEU) made a distinction of the stem cell biotechnologies based...

  • IRBs can learn from the experiences of early SCROs.  // IRB Advisor;May2007, Vol. 7 Issue 5, p49 

    The article focuses on the stem cell research oversight committees (SCRO) and the embryonic stem cell research oversight (ESCRO). Inreasing numbers of intistutions are forming SCRO committees or ESCRO committees, which often have overlapping responsibilities with international review boards. The...

  • National Academies Releases Guidelines for Embryonic Stem Cell Research. Zielinski, Sarah L. // JNCI: Journal of the National Cancer Institute;6/1/2005, Vol. 97 Issue 11, p795 

    Reports that a National Academies panel in the U.S. has recommended that institutions conducting embryonic stem cell research create embryonic stem cell research oversight committees to ensure that the panel's new guidelines are followed. Committees to be comprised of experts in biology and stem...

  • Guidelines for human embryonic stem cell research. Moreno, Jonathan D.; Hynes, Richard O. // Nature Biotechnology;Jul2005, Vol. 23 Issue 7, p793 

    The article focuses on the guidelines for human embryonic stem cell (hES) research. Responding to a lack of the U.S. government leadership on the conduct of human embryonic stem cell research, a National Academies panel has proposed the creation of new institutional oversight committees. As the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics